XML 76 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities      
Net loss $ (35,290) $ (24,037) $ (16,790)
Adjustments to reconcile net loss to net cash used in operations      
Depreciation of property and equipment 1,243 903 817
Provision for doubtful accounts 65 195 60
Amortization of patents 124 70 55
Write-off of patent costs 64 130 162
Amortization of (premium) discount on debt, net 137 (59) (68)
Debt conversion and valuation of conversion options, net 716 181 736
Stock-based compensation 10,928 7,442 5,165
Other 0 0 260
Changes in assets and liabilities      
Accounts receivable (6,718) (1,281) (391)
Inventories (6,647) 818 (1,243)
Prepaid expenses and other assets (564) 925 (379)
Accounts payable 4,624 1,484 269
Accrued expenses and other liabilities 4,480 2,464 7
Net cash used in operations (26,838) (10,765) (11,340)
Cash flows from investing activities      
Expenditures for property and equipment (12,717) (1,672) (437)
Patent acquisition costs (702) (783) (538)
Net cash used in investing activities (13,419) (2,455) (975)
Cash flows from financing activities      
Proceeds from the employee stock purchase plan 3,371 1,752 1,418
Exercise of stock options and warrants 16,262 5,927 4,428
Proceeds from borrowings 4,800 4,500 7,885
Payments on borrowings (9,850) (4,800) (1,935)
Proceeds from sale of common stock, net of issuance costs 84,369 38,209 14,889
Net cash provided by financing activities 98,952 45,588 26,685
Net change in cash and cash equivalents 58,695 32,368 14,370
Cash and cash equivalents      
Beginning of period 67,897 35,529 21,159
End of period 126,592 67,897 35,529
Noncash investing and financing activities      
Issuance and expiration of common stock warrants 92 0 497
Beneficial conversion feature on convertible debt 0 108 28
Equipment included in accounts payable 825 66 160
Patent costs included in accounts payable 90 43 0
Conversion of convertible debt 5,252 4,900 600
Net exercise of common stock warrants 4,322 1,130 335
Premium on convertible debt 0 304 267
Supplemental cash flow information      
Interest paid $ 534 $ 1,132 $ 1,383